View Older Stories View More Recent Stories
-
Discovery 2024 Short Duration LP Initial Public Offering – Maximum $25,000,000
-
Seismic Therapeutic to Participate in Upcoming Investor Conferences
-
RBC Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
-
IHS Holding (IHS) PT Lowered to $7 at RBC Capital
-
Fisher & Paykel Healthcare (FPH:NZ) (FSPKF) PT Raised to NZD26 at RBC Capital
-
Fineos Corporation Holdings plc (FCL:AU) PT Lowered to AUD1.70 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on Accent Group Ltd. (AX1:AU)
-
With stock down 73% YTD, is Evotec a broken business?
-
Sonida Provides Summary of Recent Capital Markets and Capital Allocation Activities
-
Williams-Sonoma (WSM) PT Lowered to $147 at RBC Capital
-
Williams Companies (WMB) PT Raised to $47 at RBC Capital
-
Nexxen (NEXN) PT Raised to $11 at RBC Capital
-
HCA Holdings (HCA) PT Raised to $405 at RBC Capital
-
Toronto-Dominion Bank (TD:CN) (TD) PT Lowered to Cdn$88 at RBC Capital
-
Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$144 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on Hays Plc. (HAS:LN) (HAYPF)
-
Barratt Developments Plc. (BDEV:LN) (BTDPY) PT Raised to GBP5.75 at RBC Capital
-
Evotec AG (EVT:GR) (EVO) PT Lowered to EUR12 at RBC Capital
-
Mobico Group PLC (MCG:LN) PT Raised to GBP0.70 at RBC Capital
-
Swiss Re (SREN:SW) (SSREY) PT Raised to CHF120 at RBC Capital
-
RBC Capital Upgrades Westlake Chemical (WLK) to Outperform
-
RBC Capital Downgrades Megaport Ltd. (MP1:AU) (MGPPF) to Sector Perform
-
RBC Capital Reiterates Outperform Rating on Evolent Health (EVH), discusses M&A chatter
-
RBC: Puma’s earnings was potential ‘clearing event’, near-term outlook bullish
-
Skye Bioscience (SKYE) Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab
-
Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity
-
Visteon (VC) PT Lowered to $129 at RBC Capital
-
Toll Bros. (TOL) PT Raised to $143 at RBC Capital
-
Target (TGT) PT Raised to $177 at RBC Capital
-
ONEOK Inc (OKE) PT Raised to $89 at RBC Capital
-
CareTrust REIT (CTRE) PT Raised to $31 at RBC Capital
-
WiseTech Global Ltd (WTC:AU) PT Raised to AUD115 at RBC Capital
-
Hansen Technologies Ltd (HSN:AU) PT Lowered to AUD5 at RBC Capital
-
Cleanaway Waste Management (CWY:AU) (TSPCF) PT Raised to AUD3.40 at RBC Capital
-
Breville Group Ltd. (BRG:AU) (BVILF) PT Raised to AUD27 at RBC Capital
-
Brambles Ltd. (BXB:AU) (BXBLY) PT Raised to AUD19.25 at RBC Capital
-
RBC says this company is 'an attractive M&A candidate'
-
Target stock surges as Q2 results top expectations, guidance raised
-
RBC Capital Downgrades Corporate Travel Management (CTD:AU) (CTMLF) to Sector Perform
-
GMS Announces Participation in Upcoming Investor Conferences
-
RBC Capital Reiterates Outperform Rating on Ecolab Inc. (ECL)
-
Lowe's (LOW) PT Lowered to $238 at RBC Capital
-
Kodiak Gas Services Inc (KGS) PT Raised to $31 at RBC Capital
-
Sims Metal Management Ltd. (SGM:AU) (SMUPF) PT Raised to AUD13 at RBC Capital
-
RBC Capital Downgrades Hub24 Ltd. (HUB:AU) to Sector Perform
-
As Democrats gather, investors gauge market impact from a Harris administration
-
As Democrats gather, investors gauge market impact from a Harris administration
-
As Democrats gather, investors gauge market impact from a Harris administration
-
As Democrats gather, investors gauge market impact from a Harris administration
-
As Democrats gather, investors gauge market impact from a Harris administration
